HRP20030735B1 - Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors - Google Patents

Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors

Info

Publication number
HRP20030735B1
HRP20030735B1 HR20030735A HRP20030735A HRP20030735B1 HR P20030735 B1 HRP20030735 B1 HR P20030735B1 HR 20030735 A HR20030735 A HR 20030735A HR P20030735 A HRP20030735 A HR P20030735A HR P20030735 B1 HRP20030735 B1 HR P20030735B1
Authority
HR
Croatia
Prior art keywords
4alkyl
aryl
het2
het2c1
arylc1
Prior art date
Application number
HR20030735A
Other languages
English (en)
Croatian (hr)
Inventor
Louis Nestor Ghislai Surleraux Dominique
Tom Bert Paul Wigerinck Piet
Getman Daniel
Gaston Verschueren Wim
Marie Helene Vendeville Sandrine
T.M.M.G De Bethune Marie-Pierre
Octaaf Antoon De Kerpel Jan
Leo Christiaan Moors Samuel
Augustinus De Kock Herman
Christiane Johanna Voets Marieke
Original Assignee
Tibotec Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharmaceuticals Ltd. filed Critical Tibotec Pharmaceuticals Ltd.
Publication of HRP20030735A2 publication Critical patent/HRP20030735A2/xx
Publication of HRP20030735B1 publication Critical patent/HRP20030735B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20030735A 2001-02-14 2002-02-14 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors HRP20030735B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01200529 2001-02-14
US28775801P 2001-05-02 2001-05-02
PCT/EP2002/001788 WO2002083657A2 (en) 2001-02-14 2002-02-14 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors

Publications (2)

Publication Number Publication Date
HRP20030735A2 HRP20030735A2 (en) 2005-08-31
HRP20030735B1 true HRP20030735B1 (en) 2012-02-29

Family

ID=26076833

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030735A HRP20030735B1 (en) 2001-02-14 2002-02-14 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors

Country Status (30)

Country Link
US (1) US7659404B2 (enExample)
EP (1) EP1370543B1 (enExample)
JP (1) JP4530612B2 (enExample)
KR (1) KR100870184B1 (enExample)
CN (2) CN101230067B (enExample)
AP (1) AP1504A (enExample)
AT (1) ATE343567T1 (enExample)
AU (1) AU2002302363B2 (enExample)
BG (1) BG66301B1 (enExample)
BR (1) BR0207862A (enExample)
CA (1) CA2438304C (enExample)
CY (1) CY1108073T1 (enExample)
CZ (1) CZ304273B6 (enExample)
DE (1) DE60215623T2 (enExample)
DK (1) DK1370543T3 (enExample)
EA (1) EA006096B1 (enExample)
EE (1) EE05385B1 (enExample)
ES (1) ES2275866T3 (enExample)
HR (1) HRP20030735B1 (enExample)
HU (1) HU229224B1 (enExample)
IL (2) IL157171A0 (enExample)
MX (1) MXPA03007236A (enExample)
NO (1) NO326174B1 (enExample)
NZ (1) NZ527391A (enExample)
PL (1) PL213327B1 (enExample)
PT (1) PT1370543E (enExample)
SI (1) SI1370543T1 (enExample)
SK (1) SK287582B6 (enExample)
WO (1) WO2002083657A2 (enExample)
ZA (1) ZA200306086B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073511A1 (en) 1999-05-28 2000-12-07 Virco Nv New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
EP1356082A2 (en) 2000-10-20 2003-10-29 Virco Bvba Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
ATE343567T1 (de) 2001-02-14 2006-11-15 Tibotec Pharm Ltd Breitspektrum 2-(substituierte-amino)- benzothiazol-sulfonamide hiv protease inhibitoren
US7109230B2 (en) 2002-01-07 2006-09-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
EP1520247B1 (en) 2002-07-01 2009-05-27 Tibotec Pharmaceuticals Ltd. Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance
WO2004003223A2 (en) 2002-07-01 2004-01-08 Tibotec Pharmaceuticals Ltd. New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
JP4879484B2 (ja) * 2002-08-02 2012-02-22 テイボテク・フアーマシユーチカルズ・リミテツド 広スペクトルの２−アミノ−ベンゾチアゾールスルホンアミドｈｉｖプロテアーゼ阻害剤
PL374948A1 (en) * 2002-08-02 2005-11-14 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
PL1670773T3 (pl) * 2003-09-30 2007-06-29 Tibotec Pharm Ltd Sposób wytwarzania sulfonamidów benzoksazolu i ich związków pośrednich
DE10360835A1 (de) * 2003-12-23 2005-07-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
AU2005244121B2 (en) * 2004-05-07 2012-01-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
ES2331257T3 (es) 2005-02-25 2009-12-28 Tibotec Pharmaceuticals Sintesis de precursores de inhibidores de proteasas.
AR053845A1 (es) 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
JO2841B1 (en) * 2006-06-23 2014-09-15 تيبوتيك فارماسيوتيكالز ليمتد 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
WO2011061590A1 (en) 2009-11-17 2011-05-26 Hetero Research Foundation Novel carboxamide derivatives as hiv inhibitors
JO3090B1 (ar) * 2009-12-11 2017-03-15 Janssen Sciences Ireland Uc 5- امينو-4- هيدروكسي-بنتويل اميدات
US9024038B2 (en) 2010-12-27 2015-05-05 Purdue Research Foundation Compunds and methods for treating HIV
US8987250B2 (en) 2012-04-20 2015-03-24 Gilead Sciences, Inc. Therapeutic compounds
CN104000824B (zh) * 2014-05-28 2016-07-06 中山大学 苯并五元杂环类化合物在制备抗hiv-1病毒药物中的应用
US11439608B2 (en) 2017-09-25 2022-09-13 Qun Lu Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease
CN116354903B (zh) * 2021-12-28 2025-09-09 南京药石科技股份有限公司 一种6-苯并噻唑磺酰氯的制备方法
WO2024206093A1 (en) * 2023-03-24 2024-10-03 Purdue Research Foundation Hiv-1p rotease inhibitors and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006030A1 (en) * 1993-08-24 1995-03-02 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
WO1996028463A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1999065870A2 (en) * 1998-06-19 1999-12-23 Vertex Pharmaceuticals Incorporated Sulfonamide inhibitors of aspartyl protease

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2093073T3 (es) 1990-03-09 1996-12-16 Milliken Res Corp Materiales organicos que tienen restos poli(oxialquilenos) enlazados por un grupo sulfonamido y su preparacion.
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
AU680635C (en) * 1992-08-25 2007-05-17 G.D. Searle Llc Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IS2334B (is) 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
DK0721331T3 (da) 1993-10-01 2002-02-11 Astrazeneca Ab Fremgangsmåde
JP4014220B2 (ja) 1995-01-20 2007-11-28 ジー．ディー．サール アンド カンパニー ビス−スルホンアミドヒドロキシエチルアミノ レトロ ウイルスプロテアーゼインヒビター
US6140505A (en) * 1995-03-10 2000-10-31 G. D. Searle & Co. Synthesis of benzo fused heterocyclic sulfonyl chlorides
US6861539B1 (en) * 1995-03-10 2005-03-01 G. D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6143788A (en) * 1995-03-10 2000-11-07 G.D. Searle & Co. Bis-amino acid hydroxyethlamino sulfonamide retroviral protease inhibitors
DK0815124T3 (da) 1995-03-10 2003-03-17 Searle & Co Heterocyckliske carbonylaminosyre-hydroxyethylamino-sulfonamidinhibitorer af retrovirale proteaser
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) * 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
EP0861249A1 (en) * 1995-11-15 1998-09-02 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
DE69726729T2 (de) 1996-05-20 2004-12-02 Janssen Pharmaceutica N.V. Fungizide mittel mit verbesserter bioverfügbarkeit
TR199900990T2 (xx) 1997-03-26 1999-10-21 Janssen Pharmaceutica N.V. Antifungal ve polimer ile kaplanm�� �ekirde�e haiz peletler.
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
AU2010299A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
WO1999033795A1 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
ID25551A (id) * 1997-12-24 2000-10-12 Vertex Pharma Bahan baku obat penghambat protease aspartil
ATE500823T1 (de) * 1998-06-23 2011-03-15 Us Of America Represented By The Secretary Dept Of Health And Human Services Arzneimittel zur behandlung von hiv-infizierten säugetieren
WO1999067254A2 (en) 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
AR031520A1 (es) * 1999-06-11 2003-09-24 Vertex Pharma Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion
ATE343567T1 (de) 2001-02-14 2006-11-15 Tibotec Pharm Ltd Breitspektrum 2-(substituierte-amino)- benzothiazol-sulfonamide hiv protease inhibitoren

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006030A1 (en) * 1993-08-24 1995-03-02 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
WO1996028463A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1999065870A2 (en) * 1998-06-19 1999-12-23 Vertex Pharmaceuticals Incorporated Sulfonamide inhibitors of aspartyl protease

Also Published As

Publication number Publication date
EE200300381A (et) 2003-12-15
AU2002302363B2 (en) 2008-05-01
US20040116485A1 (en) 2004-06-17
KR20030077017A (ko) 2003-09-29
BR0207862A (pt) 2004-06-22
HUP0303257A2 (hu) 2004-01-28
CY1108073T1 (el) 2014-02-12
MXPA03007236A (es) 2003-12-04
SK11022003A3 (sk) 2004-07-07
BG108143A (en) 2004-07-30
WO2002083657A3 (en) 2003-02-13
CA2438304C (en) 2011-04-12
CN100369904C (zh) 2008-02-20
SK287582B6 (sk) 2011-03-04
HU229224B1 (en) 2013-09-30
EA200300891A1 (ru) 2004-02-26
EA006096B1 (ru) 2005-08-25
PT1370543E (pt) 2007-02-28
US7659404B2 (en) 2010-02-09
NO326174B1 (no) 2008-10-13
DE60215623T2 (de) 2007-08-30
DE60215623D1 (de) 2006-12-07
DK1370543T3 (da) 2007-02-19
CN1525962A (zh) 2004-09-01
EP1370543B1 (en) 2006-10-25
AP1504A (en) 2005-12-10
NO20033584D0 (no) 2003-08-13
ZA200306086B (en) 2005-01-26
BG66301B1 (bg) 2013-03-29
ES2275866T3 (es) 2007-06-16
CN101230067A (zh) 2008-07-30
NO20033584L (no) 2003-10-14
CZ304273B6 (cs) 2014-02-12
WO2002083657A2 (en) 2002-10-24
IL157171A0 (en) 2004-02-08
PL363778A1 (en) 2004-11-29
CZ20032415A3 (cs) 2004-04-14
IL157171A (en) 2012-10-31
JP4530612B2 (ja) 2010-08-25
HRP20030735A2 (en) 2005-08-31
NZ527391A (en) 2005-04-29
SI1370543T1 (sl) 2007-04-30
HK1061233A1 (en) 2004-09-10
CN101230067B (zh) 2011-06-15
AP2003002856A0 (en) 2003-09-30
EE05385B1 (et) 2011-02-15
PL213327B1 (pl) 2013-02-28
EP1370543A2 (en) 2003-12-17
CA2438304A1 (en) 2002-10-24
KR100870184B1 (ko) 2008-11-24
ATE343567T1 (de) 2006-11-15
JP2004518767A (ja) 2004-06-24

Similar Documents

Publication Publication Date Title
HRP20030735B1 (en) Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
AR119698A2 (es) Compuesto amida n-urea sustituida derivado de aminoácido
CO4980859A1 (es) Arilpiperazinas que tienen actividad sobre el receptor 1a de la serotonina
ATE266021T1 (de) Imidazol-2-carbonsäureamid derivate als raf kinase inhibitoren
AR025386A1 (es) Moduladores de los receptores activados del proliferador de peroxisomas
AR130796A1 (es) Compuestos triheterocíclicos novedosos
CY1109247T1 (el) Αναστολεις πρωτεασης hiv σουλφοναμιδιου 2-αμινο-βενζοξαζολης ευρεως φασματος
CO6331462A2 (es) Compuesto de fenil pirrol o una sal farmaceuticamente aceptable del mismo con actividad activadora de la glucoquinasa
AR049543A1 (es) Derivados de la 1-amino-ftalazina, su preparacion y su aplicacion en terapeutica
HRP20030905B1 (en) Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
AR122092A1 (es) Inhibidores de diacilglicerol o-aciltransferasa 2
HRP20080493T3 (hr) Supstituirani kinolinski derivati kao mitotski inhibitori kinezina
AR041883A1 (es) Compuestos de piridopirimidinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AR114374A1 (es) Compuestos herbicidas
HRP20050606B1 (hr) Supstituirani oksindol sulfonamid hiv proteazni inhibitori širokog spektra
MY135226A (en) Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
AR037976A1 (es) Sulfonamidas que contienen fenilo sustituido con grupos heterociclicos, una composicion farmaceutica, un producto combinado con un agente antirretroviral y el uso de las mismas para la fabricacion de un medicamento.
AR122336A1 (es) Compuestos heterocíclicos como inhibidores de delta-5 desaturasa y métodos de uso
AR038928A1 (es) Benzimidazol sulfonamidas sustituidas, como inhibidores de amplio espectro de la proteasa del vih
FI20022159A0 (fi) Uusia farmaseuttisia yhdisteitä
AR035866A1 (es) 2-(amino sustituido)-benzotiazol sulfonamidas inhibidoras de proteasa de hiv de amplio espectro, un metodo para su preparacion, composiciones farmaceuticas que los comprenden y el uso de dichos compuestos para la manufactura de medicamentos

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20150102

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20160214